Showing results (81-90 of 146) with videos related to
Sort By:
Pageof 15
Life Sciences|July 5, 1982
Peptides in the cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide functionR M Post, P Gold, D R Rubinow, et al.The American Journal of Psychiatry|April 11, 1992
Effect of sleep deprivation on brain metabolism of depressed patientsJ C Wu, J C Gillin, M S Buchsbaum, et al.Psychiatry Research|July 1, 1984
Endocrine effects of the cold pressor test: relationships to subjective pain appraisal and copingM Bullinger, D Naber, D Pickar, et al.The American Journal of Psychiatry|April 1, 1984
CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patientsP T Ninan, D P van Kammen, M Scheinin, et al.Archives of General Psychiatry|July 1, 1996
Brain glucose metabolism during non-rapid eye movement sleep in major depression. A positron emission tomography studyA P Ho, J C Gillin, M S Buchsbaum, et al.Archives of General Psychiatry|June 1, 1983
Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant responseR M Post, T W Uhde, J C Ballenger, et al.Pharmacopsychiatria|July 1, 1981
Gamma-hydroxybutyrate treatment of schizophrenia: a pilot studyS C Schulz, D P van Kammen, M S Buchsbaum, et al.Archives of General Psychiatry|January 13, 2000
Effects of temporal variability on p50 and the gating ratio in schizophrenia: a frequency domain adaptive filter single-trial analysisJ V Patterson, Y Jin, M Gierczak, et al.Life Sciences|January 1, 1989
Regional cerebral glucose metabolic rate in human sleep assessed by positron emission tomographyM S Buchsbaum, J C Gillin, J Wu, et al.Archives of General Psychiatry|March 1, 1982
Antipsychotic effects of pimozide in schizophrenia. Treatment response prediction with acute dextroamphetamine responseD P van Kammen, J P Docherty, S R Marder, et al.Pageof 15